mucositis


Also found in: Wikipedia.

mucositis

 [mu″ko-si´tis]
inflammation of a mucous membrane.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

mucositis

(myū-kō-sī'tis),
Inflammation of a mucous membrane.
[mucosa + -itis]
Farlex Partner Medical Dictionary © Farlex 2012

mucositis

Inflammation of a mucosa which, in the GI tract, appears as oral ulcers. See Stomatitis.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

mu·co·si·tis

(myūkō-sītis)
Inflammation of a mucous membrane
[mucosa + -itis]
Medical Dictionary for the Dental Professions © Farlex 2012
References in periodicals archive ?
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today it has received a positive recommendation from the independent Data Monitoring Committee (DMC) to continue enrolling into the company's Phase 3 'DOM-INNATE' study (Dusquetide treatment in Oral Mucositis by modulating INNATE immunity) for SGX942 (dusquetide) in the treatment of oral mucositis in patients with head and neck cancer (HNC).
Soligenix has received a positive recommendation from the independent Data Monitoring Committee to continue enrolling into the company's Phase 3 "DOM-INNATE" study for SGX942 - dusquetide - in the treatment of oral mucositis in patients with head and neck cancer.
earned another SBIR grant, this time banking $150,000 to advance its study of SGX942 for pediatric indications including oral mucositis in patients with head and neck cancer.
MONDAY, July 22, 2019 (HealthDay News) -- Photobiomodulation (PBM), such as laser and other light therapies, is recommended for prevention of oral mucositis (OM) in specific populations of cancer patients, according to a review published online July 8 in Supportive Care in Cancer.
Transfusion requirements, duration of hospitalization, and frequency and duration of adverse events, including fever, neutropenia, and mucositis were evaluated during follow-up.
M2 EQUITYBITES-April 5, 2019-Soligenix expects US patent for Dusquetide related analogs in infectious disease and oral mucositis
Global Banking News-April 5, 2019-Soligenix expects US patent for Dusquetide related analogs in infectious disease and oral mucositis
M2 PHARMA-April 5, 2019-Soligenix expects US patent for Dusquetide related analogs in infectious disease and oral mucositis
Oral mucositis (OM) is a side effect related to radiation and cancer chemotherapy.
The Lite Therapy Effectiveness For Oral Mucositis (LiTEFORM) trial will discover if low-level laser treatment can help in the management of painful irritation of the mouth lining - a common and very unpleasant side effect of chemotherapy and radiotherapy.
LiTEFORM will tell doctors whether low-level laser therapy reduces the burden of painful mucositis for patients.